Actinium Pharmaceuticals, Inc. ATNM.OB is a New York based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium s targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha emitting actinium and bismuth and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The Company s lead radiopharmaceutical Iomab TM B will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. The Company is conducting a single, pivotal, multicenter Phase clinical study of Iomab B in refractory and relapsed Acute Myeloid Leukemia AML patients over the age of with a primary endpoint of durable complete remission. The company s second program, Actimab A, is continuing its clinical development in a Phase / trial for newly diagnosed AML patients over the age of in a single arm multicenter trial.
Quote | Actinium Pharmaceuticals Inc. (NYSE:ATNM)
Last: | $7.29 |
---|---|
Change Percent: | 2.53% |
Open: | $7.13 |
Close: | $7.11 |
High: | $7.38 |
Low: | $7.06 |
Volume: | 70,348 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Actinium Pharmaceuticals Inc. (NYSE:ATNM)
2024-07-11 14:23:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Low-cap biotech companies are a high-risk but high-reward investment choice. If their clinical trials are successful, that can often mean an explosion in value as investors anticipate a buyout....
2024-07-05 14:35:06 ET Summary Actinium Pharmaceuticals, Inc. is focused on developing radiolabeled biologics for blood cancer treatment, with a potential approval for Iomab-B by 2025. Positive late-stage data supports Iomab-B approval for relapsed/refractory AML patients, with a ...
Message Board Posts | Actinium Pharmaceuticals Inc. (NYSE:ATNM)
Subject | By | Source | When |
---|---|---|---|
Been watching the share price and have to | timberwolf7 | investorshub | 04/11/2023 4:24:43 AM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals Announces Dr. Sergio Giralt to Discuss Po | whytestocks | investorshangout | 02/27/2023 1:05:46 PM |
Results were definitely FDA approvable. Everyone is | Pharmboy46 | investorshub | 02/22/2023 6:38:21 PM |
What's wrong? I don't understand! Down 5$ in | blukky | investorshub | 02/22/2023 6:26:34 PM |
PUMP & DUMP | Lonewolf1 | investorshub | 02/21/2023 9:41:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Actinium Pharmaceuticals Inc. Company Name:
ATNM Stock Symbol:
NYSE Market:
Actinium Pharmaceuticals Inc. Website:
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 18, 2024) - Investorideas.com , a go-to investing platform covering biotech and medical technology stocks releases the second of a two-part series looking at developments for the treatment of blood cancers, including AML, fe...
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 17, 2024) - Investorideas.com , a go-to investing platform, releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and ...